Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1996 Sep;34(9):2175–2179. doi: 10.1128/jcm.34.9.2175-2179.1996

Diagnosis of disseminated candidiasis by measurement of urine D-arabinitol/L-arabinitol ratio.

L Lehtonen 1, V J Anttila 1, T Ruutu 1, J Salonen 1, J Nikoskelainen 1, E Eerola 1, P Ruutu 1
PMCID: PMC229212  PMID: 8862580

Abstract

Relative amounts of D-arabinitol (fungal origin) and L-arabinitol (part of normal human metabolism) in urine were determined by gas chromatography and mass spectrometry from 61 hospitalized patients with hematological malignancies. Seventeen neutropenic patients with acute leukemia (with 53 samples) had disseminated yeast infections and received empiric antifungal therapy before confirmation of the diagnosis. Control groups consisted of 22 hematologic patients (76 samples) with either mucosal (n = 10) or urinary (n = 12) Candida colonization and 22 neutropenic patients (34 samples) with no clinical or laboratory signs of invasive yeast infection. Reference values were also obtained from 50 healthy adults (50 samples). The mean urine D-arabinitol/L-arabinitol ratio +/- standard deviation (range) was 16.91 +/- 41.79 (1.41 to 254.75) in patients with disseminated infection, 2.73 +/- 2.48 (1.11 to 19.00) in colonized hematologic patients, 2.12 +/- 0.84 (1.16 to 5.84) in neutropenic controls, and 1.95 +/- 0.34 (0.97 to 3.44) in healthy adults (P < 0.001 between patients with disseminated infection and all control groups). The sensitivity and specificity of the assay for detecting disseminated yeast infection were, respectively, 88 and 91% per patient (upper limit of normal, 4.00). Seventy-one percent of patients already expressed elevated values at the onset of empiric antifungal therapy. The diagnosis of disseminated infection was confirmed on average 21.7 days after the first elevation of the D-arabinitol/L-arabinitol ratio. The method contributes to diagnosis of disseminated yeast infection and helps in monitoring patients at risk, to support the initiation of antifungal therapy at an early stage of the disease.

Full Text

The Full Text of this article is available as a PDF (209.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernard E. M., Christiansen K. J., Tsang S. F., Kiehn T. E., Armstrong D. Rate of arabinitol production by pathogenic yeast species. J Clin Microbiol. 1981 Aug;14(2):189–194. doi: 10.1128/jcm.14.2.189-194.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bernard E. M., Wong B., Armstrong D. Stereoisomeric configuration of arabinitol in serum, urine, and tissues in invasive candidiasis. J Infect Dis. 1985 Apr;151(4):711–715. doi: 10.1093/infdis/151.4.711. [DOI] [PubMed] [Google Scholar]
  3. Christensson B., Roboz J. Arabinitol enantiomers in cerebrospinal fluid. J Neurol Sci. 1991 Oct;105(2):234–239. doi: 10.1016/0022-510x(91)90150-6. [DOI] [PubMed] [Google Scholar]
  4. Gold J. W., Wong B., Bernard E. M., Kiehn T. E., Armstrong D. Serum arabinitol concentrations and arabinitol/creatinine ratios in invasive candidiasis. J Infect Dis. 1983 Mar;147(3):504–513. doi: 10.1093/infdis/147.3.504. [DOI] [PubMed] [Google Scholar]
  5. Hughes W. T., Armstrong D., Bodey G. P., Feld R., Mandell G. L., Meyers J. D., Pizzo P. A., Schimpff S. C., Shenep J. L., Wade J. C. From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis. 1990 Mar;161(3):381–396. doi: 10.1093/infdis/161.3.381. [DOI] [PubMed] [Google Scholar]
  6. Jones J. M. Laboratory diagnosis of invasive candidiasis. Clin Microbiol Rev. 1990 Jan;3(1):32–45. doi: 10.1128/cmr.3.1.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Larsson L., Pehrson C., Wiebe T., Christensson B. Gas chromatographic determination of D-arabinitol/L-arabinitol ratios in urine: a potential method for diagnosis of disseminated candidiasis. J Clin Microbiol. 1994 Aug;32(8):1855–1859. doi: 10.1128/jcm.32.8.1855-1859.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lehtonen L., Rantala A., Oksman P., Eerola E., Lehtonen O. P. Determination of serum arabinitol levels by mass spectrometry in patients with postoperative candidiasis. Eur J Clin Microbiol Infect Dis. 1993 May;12(5):330–335. doi: 10.1007/BF01964428. [DOI] [PubMed] [Google Scholar]
  9. Maksymiuk A. W., Thongprasert S., Hopfer R., Luna M., Fainstein V., Bodey G. P. Systemic candidiasis in cancer patients. Am J Med. 1984 Oct 30;77(4D):20–27. [PubMed] [Google Scholar]
  10. Rantala A., Niinikoski J., Lehtonen O. P. Yeasts in blood cultures: impact of early therapy. Scand J Infect Dis. 1989;21(5):557–561. doi: 10.3109/00365548909037885. [DOI] [PubMed] [Google Scholar]
  11. Reiss E., Morrison C. J. Nonculture methods for diagnosis of disseminated candidiasis. Clin Microbiol Rev. 1993 Oct;6(4):311–323. doi: 10.1128/cmr.6.4.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Roboz J., Katz R. N. Diagnosis of disseminated candidiasis based on serum D/L-arabinitol ratios using negative chemical ionization mass spectrometry. J Chromatogr. 1992 Mar 27;575(2):281–286. doi: 10.1016/0378-4347(92)80157-l. [DOI] [PubMed] [Google Scholar]
  13. Roboz J., Nieves E., Holland J. F. Separation and quantification by gas chromatography-mass spectrometry of arabinitol enantiomers to aid the differential diagnosis of disseminated candidiasis. J Chromatogr. 1990 Feb 2;500:413–426. doi: 10.1016/s0021-9673(00)96082-5. [DOI] [PubMed] [Google Scholar]
  14. Switchenko A. C., Miyada C. G., Goodman T. C., Walsh T. J., Wong B., Becker M. J., Ullman E. F. An automated enzymatic method for measurement of D-arabinitol, a metabolite of pathogenic Candida species. J Clin Microbiol. 1994 Jan;32(1):92–97. doi: 10.1128/jcm.32.1.92-97.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. TOUSTER O., SHAW D. R. Biochemistry of the acyclic polyols. Physiol Rev. 1962 Apr;42:181–225. doi: 10.1152/physrev.1962.42.2.181. [DOI] [PubMed] [Google Scholar]
  16. Walsh T. J., Lee J. W., Sien T., Schaufele R., Bacher J., Switchenko A. C., Goodman T. C., Pizzo P. A. Serum D-arabinitol measured by automated quantitative enzymatic assay for detection and therapeutic monitoring of experimental disseminated candidiasis: correlation with tissue concentrations of Candida albicans. J Med Vet Mycol. 1994;32(3):205–215. doi: 10.1080/02681219480000271. [DOI] [PubMed] [Google Scholar]
  17. Walsh T. J., Merz W. G., Lee J. W., Schaufele R., Sein T., Whitcomb P. O., Ruddel M., Burns W., Wingard J. R., Switchenko A. C. Diagnosis and therapeutic monitoring of invasive candidiasis by rapid enzymatic detection of serum D-arabinitol. Am J Med. 1995 Aug;99(2):164–172. doi: 10.1016/s0002-9343(99)80136-3. [DOI] [PubMed] [Google Scholar]
  18. Wells C. L., Sirany M. S., Blazevic D. J. Evaluation of serum arabinitol as a diagnostic test for candidiasis. J Clin Microbiol. 1983 Aug;18(2):353–357. doi: 10.1128/jcm.18.2.353-357.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wong B., Baughman R. P., Brauer K. L. Levels of the Candida metabolite D-arabinitol in sera of steroid-treated and untreated patients with sarcoidosis. J Clin Microbiol. 1989 Aug;27(8):1859–1862. doi: 10.1128/jcm.27.8.1859-1862.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wong B., Bernard E. M., Gold J. W., Fong D., Silber A., Armstrong D. Increased arabinitol levels in experimental candidiasis in rats: arabinitol appearance rates, arabinitol/creatinine ratios, and severity of infection. J Infect Dis. 1982 Sep;146(3):346–352. doi: 10.1093/infdis/146.3.346. [DOI] [PubMed] [Google Scholar]
  21. Wong B., Brauer K. L., Clemens J. R., Beggs S. Effects of gastrointestinal candidiasis, antibiotics, dietary arabinitol, and cortisone acetate on levels of the Candida metabolite D-arabinitol in rat serum and urine. Infect Immun. 1990 Feb;58(2):283–288. doi: 10.1128/iai.58.2.283-288.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Wong B., Brauer K. L. Enantioselective measurement of fungal D-arabinitol in the sera of normal adults and patients with candidiasis. J Clin Microbiol. 1988 Sep;26(9):1670–1674. doi: 10.1128/jcm.26.9.1670-1674.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wong B., Castellanos M. Enantioselective measurement of the Candida metabolite D-arabinitol in human serum using multi-dimensional gas chromatography and a new chiral phase. J Chromatogr. 1989 Oct 27;495:21–30. doi: 10.1016/s0378-4347(00)82606-7. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES